Please click HERE to download a copy of our letter.
To Our Valued Clinicians, Patients, Partners, and Colleagues:
As many of you know, the Corus® CAD test will no longer be available in the near future and CardioDx will be ceasing operations. In light of recent reports regarding CardioDx, we felt it would be helpful to provide additional context regarding this difficult situation.
Corus CAD has been a covered Medicare benefit since 2012. There are 30 peer‐reviewed publications supporting the clinical validity and clinical utility of the test, including the use of the test in the Medicare patient population. CardioDx is unaware of any concerns relative to the safety of the Corus CAD test.
In addition to the published evidence, Corus CAD was favorably mentioned by the American Heart Association in a Scientific Statement published in 2017. As recently as November of 2018 the company presented additional data at two scientific meetings (American Heart Association and Gerontological Society of America) supporting the clinical utility of the test, including in the elderly population. (click here to read the press releases)
Since learning of Medicare’s intention to remove Corus CAD as a covered benefit, CardioDx has had numerous discussions with the Medicare Administrative Contractor (Palmetto) regarding how clinicians use the Corus CAD test and if those clinical decisions lead to better patient outcomes. Unfortunately, Palmetto ultimately determined that they will no longer provide reimbursement for the Corus CAD test.
The CardioDx team is disappointed with this outcome and knows that many of you have found clinical value in the Corus CAD test. We appreciate the overwhelming support we have received from the clinical community.
The last day we will be accepting samples into our laboratory will be Thursday, January 17, 2019. If you have additional questions, please feel free to reach out to your Genomic Sales Specialists or call Customer Service at 866.941.4996. We thank you for your support and feedback over the years. It has been our privilege to work with you.
The CardioDx Team